Neurones SA
PAR:NRO

Watchlist Manager

Neurones SA

PAR:NRO

Watchlist

Dividends

Discount Rate

Price: 43.9 EUR -0.68%

Market Cap: 1.1B EUR

Have any thoughts about
Neurones SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 43.9 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

NRO Alert

Neurones SA

43.9

-0.3 (-0.68%)

52 Week Range	40.25 47.55
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Neurones SA

What unique competitive advantages
does Neurones SA hold over its rivals?

What risks and challenges
does Neurones SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Neurones SA.

What unique competitive advantages
does Neurones SA hold over its rivals?

What risks and challenges
does Neurones SA face in the near future?

Has there been any significant insider trading activity
in Neurones SA recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Neurones SA.

Provide P/S
for Neurones SA.

Provide P/E
for Neurones SA.

Provide P/OCF
for Neurones SA.

Provide P/FCFE
for Neurones SA.

Provide P/B
for Neurones SA.

Provide EV/S
for Neurones SA.

Provide EV/GP
for Neurones SA.

Provide EV/EBITDA
for Neurones SA.

Provide EV/EBIT
for Neurones SA.

Provide EV/OCF
for Neurones SA.

Provide EV/FCFF
for Neurones SA.

Provide EV/IC
for Neurones SA.

Show me price targets
for Neurones SA made by professional analysts.

What are the Revenue projections
for Neurones SA?

How accurate were the past Revenue estimates
for Neurones SA?

What are the Net Income projections
for Neurones SA?

How accurate were the past Net Income estimates
for Neurones SA?

What are the EPS projections
for Neurones SA?

How accurate were the past EPS estimates
for Neurones SA?

What are the EBIT projections
for Neurones SA?

How accurate were the past EBIT estimates
for Neurones SA?

Compare the revenue forecasts
for Neurones SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Neurones SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Neurones SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Neurones SA compared to its peers.

Compare the P/E ratios
of Neurones SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Neurones SA with its peers.

Analyze the financial leverage
of Neurones SA compared to its main competitors.

Show all profitability ratios
for Neurones SA.

Provide ROE
for Neurones SA.

Provide ROA
for Neurones SA.

Provide ROIC
for Neurones SA.

Provide ROCE
for Neurones SA.

Provide Gross Margin
for Neurones SA.

Provide Operating Margin
for Neurones SA.

Provide Net Margin
for Neurones SA.

Provide FCF Margin
for Neurones SA.

Show all solvency ratios
for Neurones SA.

Provide D/E Ratio
for Neurones SA.

Provide D/A Ratio
for Neurones SA.

Provide Interest Coverage Ratio
for Neurones SA.

Provide Altman Z-Score Ratio
for Neurones SA.

Provide Quick Ratio
for Neurones SA.

Provide Current Ratio
for Neurones SA.

Provide Cash Ratio
for Neurones SA.

What is the historical Revenue growth
over the last 5 years for Neurones SA?

What is the historical Net Income growth
over the last 5 years for Neurones SA?

What is the current Free Cash Flow
of Neurones SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Neurones SA.

EV/EBITDA
Enterprise Value to EBITDA

9.2

Current

7.8

Median

12.9

Industry

Higher than median

Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

9.2

Enterprise Value

836.6m EUR

EBITDA

91.3m EUR

All Countries

Forward Multiples

		Market Cap	EV/EBITDA
FR	Neurones SA PAR:NRO	1.1B EUR	9.2
IE	Accenture PLC NYSE:ACN	225B USD	17.7
US	International Business Machines Corp NYSE:IBM	205.3B USD	17.8
IN	Tata Consultancy Services Ltd NSE:TCS	15.1T INR	21.9
IN	Infosys Ltd NSE:INFY	7.9T INR	20.6
IN	HCL Technologies Ltd NSE:HCLTECH	5.1T INR	20
US	Cognizant Technology Solutions Corp NASDAQ:CTSH	39.2B USD	12.8
IN	Wipro Ltd NSE:WIPRO	3.2T INR	16.1
US	Gartner Inc NYSE:IT	37.8B USD	28.5
JP	Fujitsu Ltd TSE:6702	5T JPY	13.5
FR	Capgemini SE PAR:CAP	26.9B EUR	8.9

			EBITDA Growth	EV/EBITDA to Growth
FR	Neurones SA PAR:NRO	Average EV/EBITDA: 17 9.2	N/A	N/A
IE	Accenture PLC NYSE:ACN	17.7	28%	0.6
US	International Business Machines Corp NYSE:IBM	17.8	36%	0.5
IN	Tata Consultancy Services Ltd NSE:TCS	21.9	33%	0.7
IN	Infosys Ltd NSE:INFY	20.6	34%	0.6
IN	HCL Technologies Ltd NSE:HCLTECH	20	32%	0.6
US	Cognizant Technology Solutions Corp NASDAQ:CTSH	12.8	18%	0.7
IN	Wipro Ltd NSE:WIPRO	16.1	24%	0.7
US	Gartner Inc NYSE:IT	28.5	42%	0.7
JP	Fujitsu Ltd TSE:6702	13.5	27%	0.5
FR	Capgemini SE PAR:CAP	8.9	17%	0.5

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

8.5

2-Years Forward

EV/EBITDA

6.8

3-Years Forward

EV/EBITDA

N/A

	Franklin Covey Co NYSE:FC	36.481 USD 0.5%
	Mohawk Industries Inc NYSE:MHK	118.87 USD -0.56%
	Ardmore Shipping Corp NYSE:ASC	12.2 USD 2.69%
	ASGN Inc NYSE:ASGN	83.55 USD -0.01%
	Skyworks Solutions Inc NASDAQ:SWKS	90.59 USD 0.44%
	Weatherford International PLC NASDAQ:WFRD	68.395 USD 2.43%

	Johnson & Johnson NYSE:JNJ	145.29 USD 0.01%
	Bank of America Corp NYSE:BAC	44.18 USD 0.66%
	Mastercard Inc NYSE:MA	532.57 USD 0.68%
	Salesforce Inc NYSE:CRM	342.91 USD 0%
	Abbvie Inc NYSE:ABBV	179.2 USD 0.45%
	Home Depot Inc NYSE:HD	393.13 USD 0.22%

	Arista Networks Inc NYSE:ANET	113.59 USD 0.44%
	Visa Inc NYSE:V	320.74 USD 1.11%
	Texas Pacific Land Corp NYSE:TPL	1 160.525 USD 1.85%
	KLA Corp NASDAQ:KLAC	648 USD 0.73%
	Manhattan Associates Inc NASDAQ:MANH	280.56 USD 0.62%
	Pinduoduo Inc NASDAQ:PDD	100.01 USD -0.57%

	Salesforce Inc NYSE:CRM	342.91 USD 0%
	Accenture PLC NYSE:ACN	359.76 USD 0.28%
	ServiceNow Inc NYSE:NOW	1 098.91 USD 0.98%
	EOG Resources Inc NYSE:EOG	120.265 USD 0.35%
	Copart Inc NASDAQ:CPRT	58.58 USD 0.38%
	Applied Materials Inc NASDAQ:AMAT	167.635 USD 0.1%

Neurones SA
PAR:NRO

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Neurones SA PAR:NRO

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Neurones SA
PAR:NRO

EV/EBITDA
Enterprise Value to EBITDA